Therapy Dog Visits for Injury
Recruiting1 award1 criteria
Boston, Massachusetts
This trial will look at how therapy dog visits can affect pain and anxiety levels in trauma patients at Boston Medical Center. Previous studies have shown that animal therapy with dogs can help patients with various illnesses and even
Behavioral Intervention
BEAM Program for Parental Mental Health
Recruiting1 award1 criteria
Winnipeg, Manitoba
This trial aims to test a program called Building Emotional Awareness and Mental Health (BEAM) designed to help parents of young children improve their mental health. The trial will involve 400 parent participants with children
Behavioral Intervention
Cognitive Behavioral Affective Therapy for Anger
Recruiting0 awards
San Antonio, Texas
This trial aims to test the effectiveness of Cognitive Behavioral Affective Therapy (CBAT) in helping people who struggle with excessive anger. The therapy teaches techniques to manage anger by recognizing triggers and using calming strategies. The goal is to reduce the negative impact of anger on health and behavior.
Behavioral Intervention
STEP Home Workshop for Veteran Reintegration and Suicide Prevention
Recruiting1 award
Boston, Massachusetts
This trial will develop a workshop to help transitioning Veterans get suicide prevention education, skills to manage transition, & support for VA healthcare to reduce suicide risk.
Popular Filters
Trials for Langerhans Cell Histiocytosis Patients
Kinase Inhibitor
DAY101 for Langerhans Cell Histiocytosis
Recruiting1 awardPhase 2
Grand Rapids, Michigan
This trial tests the safety and effectiveness of tovorafenib (DAY101) in children and young adults with Langerhans cell histiocytosis that is worsening, has returned, or does not respond to other treatments. Tovorafenib is taken orally and works by blocking enzymes needed for cancer cell growth. The study aims to find the best dose and observe the response and side effects over time.
Anti-metabolites
Vinblastine/Prednisone vs. Cytarabine for Histiocytosis
Recruiting4 awardsPhase 3
San Diego, California
This trial is comparing two treatments for Langerhans Cell Histiocytosis (LCH), a cancer that begins in LCH cells. One treatment is standard-of-care vinblastine/prednisone, while the other is cytarabine therapy. The purpose is to see if cytarabine is more effective than vinblastine/prednisone, and if so, to develop it as the new front-line therapy for LCH.
Chemotherapy
Combination Therapy for Langerhans Cell Histiocytosis
Recruiting1 awardPhase 2 & 3
Birmingham, Alabama
This trial uses a combination of two drugs, vinblastine and prednisone, to treat children with Langerhans Cell Histiocytosis. The treatment works by stopping abnormal cell growth and reducing inflammation. Vinblastine and prednisone have been used in various combinations to treat Langerhans Cell Histiocytosis (LCH) with some success in managing symptoms and achieving remission.
Trials for LCH Patients
Kinase Inhibitor
DAY101 for Langerhans Cell Histiocytosis
Recruiting1 awardPhase 2
Grand Rapids, Michigan
This trial tests the safety and effectiveness of tovorafenib (DAY101) in children and young adults with Langerhans cell histiocytosis that is worsening, has returned, or does not respond to other treatments. Tovorafenib is taken orally and works by blocking enzymes needed for cancer cell growth. The study aims to find the best dose and observe the response and side effects over time.
Anti-metabolites
Vinblastine/Prednisone vs. Cytarabine for Histiocytosis
Recruiting4 awardsPhase 3
San Diego, California
This trial is comparing two treatments for Langerhans Cell Histiocytosis (LCH), a cancer that begins in LCH cells. One treatment is standard-of-care vinblastine/prednisone, while the other is cytarabine therapy. The purpose is to see if cytarabine is more effective than vinblastine/prednisone, and if so, to develop it as the new front-line therapy for LCH.
Chemotherapy
Combination Therapy for Langerhans Cell Histiocytosis
Recruiting1 awardPhase 2 & 3
Birmingham, Alabama
This trial uses a combination of two drugs, vinblastine and prednisone, to treat children with Langerhans Cell Histiocytosis. The treatment works by stopping abnormal cell growth and reducing inflammation. Vinblastine and prednisone have been used in various combinations to treat Langerhans Cell Histiocytosis (LCH) with some success in managing symptoms and achieving remission.
Trials With No Placebo
Behavioral Intervention
BEAM App for Parent Mental Health
Recruiting1 award5 criteria
Vancouver, British Columbia
This trial tests an app called BEAM designed to help parents with young children manage depression, anxiety, and anger. The app offers videos, exercises, peer coaching, and social support. It aims to improve parent mental health and reduce parenting stress, which can benefit both the parents and their children. The BEAM program has shown promise in reducing depressive symptoms in adolescents with ADHD.
Behavioral Intervention
Parent Management Training for Irritability
Recruiting1 award
Aurora, Colorado
This trial aims to see if they can enroll 30 children with significant irritability, provide Parent Management Training (PMT), and measure their physiology before and after the training. They want to show that
Kinase Inhibitor
DAY101 for Langerhans Cell Histiocytosis
Recruiting1 awardPhase 2
Grand Rapids, Michigan
This trial tests the safety and effectiveness of tovorafenib (DAY101) in children and young adults with Langerhans cell histiocytosis that is worsening, has returned, or does not respond to other treatments. Tovorafenib is taken orally and works by blocking enzymes needed for cancer cell growth. The study aims to find the best dose and observe the response and side effects over time.
Behavioral Intervention
Behavioral Therapy for Autism
Recruiting1 award1 criteria
New Haven, Connecticut
This trial tests a new therapy called BTIA, which helps teens with autism manage their emotions and behaviors. The therapy involves regular sessions where therapists teach both the teens and their parents how to handle frustration and improve daily functioning. The study aims to see if BTIA can reduce disruptive behaviors and help these teens function better in their everyday lives.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.